Antiandrogens in the treatment of priapism

Philipp Dahm, Dinesh S. Rao, Craig F. Donatucci

Research output: Contribution to journalArticlepeer-review

62 Scopus citations


Recurrent priapism in young men is a potentially devastating condition that may result in irreversible penile fibrosis. Hormonal manipulation using estrogens and gonadotropin-releasing hormone analogues has been successful in treating episodes of priapism refractory to other treatment forms, but it is associated with significant adverse effects, in particular the loss of libido and erectile function. We present 2 patients with sickle-cell disease and 1 patient with a spinal cord injury who had recurrent and refractory priapism. All 3 patients were successfully treated with low-dose antiandrogens without major side effects. Our observations suggest a role for antiandrogens in the treatment of men with refractory priapism that should be evaluated in the setting of a controlled study.

Original languageEnglish (US)
Pages (from-to)138
Number of pages1
Issue number1
StatePublished - 2002


Dive into the research topics of 'Antiandrogens in the treatment of priapism'. Together they form a unique fingerprint.

Cite this